59
The TAB1-p38a complex is a therapeutic target in acute myocardial ischemia: the holy grail of circumstance selective inhibition of p38a

Cardiovascular Research

23 April 2018

Organised by:

Read full article

Contributors

G F De Nicola

G F De Nicola

Author

R Bassi

R Bassi

Author

E V Martin

E V Martin

Author

M Caggiano Fernandez

M Caggiano Fernandez

Author

C Nichols

C Nichols

Author

R Anderson

R Anderson

Author

D Thapa

D Thapa

Author

J Clark

J Clark

Author

M S Marber

M S Marber

Author

You may be interested in

Congress Presentation

New therapeutic strategy targeting regulation of the SERCA2 complex protects from myocardial ischemia-reperfusion injury

28 August 2023

Congress Session

Challenges in the treatment of myocardial infarction

18 May 2025

Congress Presentation

Current challenges in pharmacological treatment of Takotsubo syndrome: is there a long way to go?

15 March 2025

Congress Presentation

A novel drug candidate targeting the adrenergic regulation of the SERCA2 complex protect the heart from myocardial infarct injury

21 May 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources